Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

Total output to increase to 51 metric tonnes annually by end of 2018

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…

Study: Adolescent Cannabis Use Not Independently Linked With IQ Decline

nvestigators concluded, "Short-term cannabis use in adolescence does not appear to cause IQ decline or impair executive functions, even when cannabis use reaches the level of dependence."

ARIZONA: The habitual use of cannabis by teens is not independently linked with adverse changes in intelligence quotient or executive functioning, according to longitudinal data published online ahead of print in the journal Addiction. A team of investigators from the United States and the United Kingdom evaluated whether marijuana use is directly associated with changes over time in neuropsychological Read the full article…

Report: CBD Interacts with Anti-Epileptic Drugs

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used anti-epileptic drugs.

New research published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that an investigational neurological treatment derived from cannabis may alter the blood levels of commonly used anti-epileptic drugs. It is important for clinicians to consider such drug interactions during treatment of complex conditions. Cannabidiol (CBD), a compound developed from the cannabis plant, Read the full article…

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill For Cannabinoid Therapies

Intec Pharma Reports Clinical Results From Phase I Trial of Accordion Pill for Cannabinoid Therapies

ISRAEL: Intec Pharma, a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the results from a Phase I clinical trial of AP-CBD/THC, its Accordion Pill platform with cannabidiol (CBD) and tetrahydrocannabinol (THC), the two primary cannabinoids contained in Cannabis sativa. “We’re excited about these encouraging results from our Read the full article…

Why Cannabis Is A Medication That’s Worth Legalizing

Why Cannabis Infographic

Chronic pain is a large problem.  Not only does 1/3 America suffer from it, but because the pain is both subjective and personal, it has been very difficult to treat. In fact, until the 1990s, it went largely under treated until opioid prescriptions began to rapidly increase. Today, we have an epidemic. But, while marijuana Read the full article…

Case Reports: Cannabis Smoking Associated With Spontaneous Remission Of Restless Legs Syndrome

Muscles - Legs Front - Fitness for You

FRANCE: Cannabis inhalation alleviates symptoms in patients with restless legs syndrome (RLS), according to a series of case reportspublished in the journal Sleep Medicine. Up to ten percent of the US population is estimated to suffer from RLS. French researchers reported on the experience of six patients with treatment-resistant RLS following cannabis inhalation. All patients reported “total relief of RLS Read the full article…

A Deeper Look Into THC, CBD and Their Differences (Infographic by Greencamp)

Screenshot 2017-07-07 10.20.08

When we talk about cannabis and its medicinal properties we simply can’t avoid its unique chemical composition, which is what’s responsible for its popularity in the first place. What makes every marijuana strain unique is its very own profile of cannabinoids and terpenes, intertwined in such a way that each strain helps with something. But Read the full article…

Study: Vaporization Offers “Attractive Alternative” To Smoked Cannabis

\

MARYLAND: Vaporizing cannabis mitigates subjects’ exposure to carbon monoxide and allows them to self-regulate their dose – making it preferable over smoking or oral administration, according to clinical trial data published in the journal Drug and Alcohol Dependence. Investigators affiliated with the US National Institute on Drug Abuse (NIDA) assessed the effects of smoked, vaporized, and oral cannabis administration Read the full article…

Study: CBD Administration Reduces Blood Pressure

Gov. Butch Otter has vetoed the bill that would have allowed parents of Idaho children with an intractable form of epilepsy to treat their kids with cannabidiol.

UNITED KINGDOM: Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation. Investigators from the University of Nottingham assessed the effects of a single oral dose of 600 mg of CBD extract versus placebo in nine male subjects. Cannabidiol administration reduced resting systolic blood Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

Tilray clinical trials progress

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…